PharmaBoardroom

The German Biotech Behind Pfizer’s COVID-19 Vaccine Candidate

German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant Pfizer on a COVID-19 vaccine. The…

Hilde Bech – General Manager, BMS Norway

BMS Norway’s Hilde Bech outlines her hopes of bringing "the medicines of the future" to Norwegian patients, why tiny Norway still has global…

Etleva (Eva) Kadilli – Director (Supply Division), UNICEF

UNICEF’s Eva Kadilli outlines the work that the organisation’s supply division is undertaking in the global push for a COVID-19 vaccine, the…

Axel B Müller – Managing Director, Intergenerika,…

Intergenerika’s Dr Axel B. Müller makes an impassioned case against the introduction of a reference pricing system in Switzerland, arguing that it…

Katharina Gasser – Managing Director, Biogen Switzerland…

Biogen Switzerland’s Dr Katharina Gasser outlines how the company’s 100 percent commitment to neuroscience helps it to stand apart, why…

Belgium Appoints ‘Corona Commissioner’ to Coordinate COVID-19…

The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of Pedro Facon, director general for…

Top 5 Polish Pharma Companies

Every year, Polish news magazine Wprost publishes its ranking of the top 200 Polish companies across all industries. Here, we profile the top five…

Peter L. Saltonstall – President & CEO, National…

Ahead of the 2020 US National Organization for Rare Disorders (NORD)’s Rare Diseases and Orphan Products Breakthrough Summit, NORD president and CEO…

Asia-Pacific: Hiring the Right Healthtech CFO Can Be Tough; It…

Robert Hall of Hong Kong-based executive recruitment specialist Ardent Search highlights the key traits and experiences that Asian biotech and medtech…

Pharmacovigilance: Steadying the Ship Through the COVID-19 Storm

Michael Levy, head of pharmacovigilance at Bayer Pharma and Bayer Consumer Health, makes a compelling case for the critical role of pharmacovigilance…

Paying for Cell & Gene Therapy in the USA: Is the Future…

Certara’s Ulrich Neumann looks at the challenges that payment models for cell and gene therapy (CGT) have faced, the multiple models now under…

Erik W. Jakobsen – Partner & Co-Founder, Menon…

Erik W. Jakobsen of Norwegian consultancy Menon Economics gives an overview of the key dynamics at play in Norway’s economy today and the growing…

Tagged with